Actinium Pharmaceuticals, Inc. reports

Company location: New York, NY
Fiscal year end: 31 December

Actinium Pharmaceuticals, Inc. has filed 494 SEC EDGAR filings since 05 Feb 2007

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 1-20 of 20 matching filings.

Per page

Current page

10-K File 001-36374

ANNUAL REPORT

Filing date: 30 Mar 2026
Reporting date: 31 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-36374

ANNUAL REPORT

Filing date: 31 Mar 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-36374

ANNUAL REPORT

Filing date: 29 Mar 2024
Reporting date: 31 Dec 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-36374

ANNUAL REPORT

Filing date: 31 Mar 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-36374

ANNUAL REPORT

Filing date: 25 Mar 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-36374

ANNUAL REPORT

Filing date: 31 Mar 2021
Reporting date: 31 Dec 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K/A File 001-36374

AMENDMENT NO. 2 TO FORM 10-K

Filing date: 13 Jul 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K/A File 001-36374

AMENDMENT NO.1 TO FORM 10-K

Filing date: 16 Jun 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-36374

ANNUAL REPORT

Filing date: 08 May 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-36374

ANNUAL REPORT

Filing date: 15 Mar 2019
Reporting date: 31 Dec 2018
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-36374

ANNUAL REPORT

Filing date: 16 Mar 2018
Reporting date: 31 Dec 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-36374

ANNUAL REPORT

Filing date: 16 Mar 2017
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-36374

ANNUAL REPORT

Filing date: 11 Mar 2016
Reporting date: 31 Dec 2015
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-36374

ANNUAL REPORT

Filing date: 16 Mar 2015
Reporting date: 31 Dec 2014
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K/A File 001-36374

AMENDMENT TO ANNUAL REPORT

Filing date: 10 Apr 2014
Reporting date: 31 Dec 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 000-52446

ANNUAL REPORT

Filing date: 28 Feb 2014
Reporting date: 31 Dec 2013
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-52446

ANNUAL REPORT

Filing date: 29 Mar 2013
Reporting date: 31 Dec 2012
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-52446

DECEMBER 31, 2011 10-K

Filing date: 12 Apr 2012
Reporting date: 31 Dec 2011
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 000-52446

DECEMBER 31, 2010 10K

Filing date: 03 Mar 2011
Reporting date: 31 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 000-52446

DECEMBER 31, 2009 10K

Filing date: 16 Mar 2010
Reporting date: 31 Dec 2009
SEC evidence: Open document Open filing
Next action: Verify source filing